What the diagnosis report needs to make clear
A drug-resistant epilepsy diagnosis is not a single document. It is a conclusion drawn from seizure descriptions, EEG recordings, imaging and the medicine history. When you send records to a hospital in China, the reviewing clinician needs to reconstruct that reasoning rather than accept the label. If the report only states 'drug-resistant epilepsy' without the underlying observations, the team cannot tell whether the conclusion is solid, whether some seizures were never captured, or whether an earlier trial of medicines was adequate.
The practical question is not whether your file is thick. It is whether a neurologist who has never met you can see what happened, when it happened and what was already excluded. A report that answers those points gives the review something to work with. A report that does not will generate requests for more information before any clinical opinion is possible.
This matters more for epilepsy than for many conditions because the diagnosis depends heavily on description. Seizure type, frequency, duration, triggers and the patient's awareness during events all shape which treatments are considered. If those details are missing or contradictory across documents, the review starts with a gap rather than a case.
Seizure records: what was actually observed
Seizure records should distinguish what a witness saw from what the patient remembers. A report that says 'frequent seizures' is far less useful than one that describes a specific event: what the person was doing, whether awareness was lost, which body parts moved, how long it lasted and how they were afterwards. These details help a clinician classify seizure type, which in turn affects whether a surgical assessment is even relevant.
The record should also make the timeline visible. When did seizures start? Have they changed in frequency or character? Were there periods of control followed by relapse? A stable pattern and a worsening pattern point in different directions, and the reviewing team needs to know which one applies.
If home video exists, note whether it has been reviewed by a clinician and what that review concluded. Video can be valuable, but only if someone has interpreted it. A file that includes raw clips without any clinical comment leaves the same gap as a vague written description.
Ask the current treating team to clarify: which seizure types are documented, how frequency is counted, and whether any events remain unclassified. Those answers determine what the China review can and cannot address.
EEG records: which test, when, and what it showed
EEG is not one test. A routine scalp EEG, a sleep-deprived EEG, an ambulatory recording over days and a video-EEG admission answer different questions. The diagnosis report should state which type was performed, the date, the duration and the clinical question it was meant to address. Without that, a reviewing clinician cannot judge how much weight the findings carry.
The report should also say what the EEG did not show. A normal interictal EEG does not exclude epilepsy, and an abnormal one does not by itself localise the seizure onset. If earlier reports describe discharges but not their distribution or timing, the review may need the original traces rather than the summary letter.
Timing matters. An EEG from several years ago may not reflect the current pattern, particularly if medicines have changed. The report should make clear whether the most recent recording is recent enough to inform a present-day decision, or whether the treating team considers repeat study necessary.
Ask whether the original EEG files, not only the written interpretation, can be shared. Many hospitals can review digital traces; a summary paragraph often cannot substitute for them.
Medicines already tried: the detail that defines drug resistance
Drug-resistant epilepsy is defined by failure of adequate trials of medicines, so the medicine history is central. The report should list each anti-seizure medicine tried, the dose reached, how long it was taken, whether it was stopped for lack of benefit or for side effects, and what happened afterwards. 'Tried several medicines' does not allow a reviewer to assess whether the trials were adequate.
The report should also note current medicines, doses and any recent changes. If a change was made shortly before the records were compiled, the reviewing team needs to know that the current pattern may not yet be stable. That affects how much weight to place on recent seizure frequency.
Side effects and tolerability belong in the record too. A medicine that controlled seizures but caused unacceptable effects tells a different story from one that simply did not work. Both are relevant to what options remain.
Ask the treating team to confirm which medicine trials they consider adequate and which they consider incomplete. That distinction often determines whether a case is genuinely drug-resistant or whether an alternative medicine trial is still reasonable.
What a multidisciplinary evaluation adds, and what it cannot decide remotely
Epilepsy surgery can be considered for selected people whose seizures are not controlled by medicines, and assessment examines potential benefits and risks. That assessment is typically multidisciplinary: neurology, neuroradiology, neuropsychology and sometimes neurosurgery contribute different views. A records-based review can identify whether such an evaluation is worth arranging, but it cannot complete it.
The diagnosis report should therefore make clear what has already been assessed and what has not. Has imaging been reviewed by a neuroradiologist? Has neuropsychological testing been done? Have the seizure and EEG findings been discussed together at a team meeting? If any of these steps are missing, the China review may recommend them rather than offer a conclusion.
A remote opinion also cannot confirm eligibility for any procedure. It can indicate whether the records suggest a case worth evaluating in person, and what further information the hospital would need. The hospital decides suitability after its own assessment.
Ask the reviewing team to state explicitly what remains uncertain and what they would need to resolve it. A useful report says 'this is unclear and here is what would clarify it', not 'this looks like a candidate'.
Preparing the file and the questions to send with it
Before approaching a hospital in China, organise the records so the clinical story is visible in order. A short cover summary written by the current treating team is more useful than a folder of unlabelled scans. It should state the diagnosis, when it was made, the seizure types and frequency, the medicines tried, the EEG and imaging performed, and the specific question you want answered.
Include the reports that support each statement, not only the most recent. If earlier EEGs or medicine trials are relevant, send them or note where they are. If something is missing, say so rather than leaving the reviewer to discover the gap.
The questions to send are as important as the records. Ask whether the file is sufficient for a meaningful review, what additional information would help, and whether the team considers an in-person assessment appropriate. Ask what the review can and cannot conclude at this stage.
For practical planning, the ChinaSpecialistCare team can check the available diagnosis and records, identify missing information and suggest a relevant next step through a free initial enquiry. A proxy consultation is optional and not a prerequisite. You can start with a brief summary by the enquiry form, email or WhatsApp, and share fuller records after first contact.
Keep the enquiry focused on the epilepsy question rather than sending a complete medical archive immediately. The hospital, not the coordination team, decides whether an assessment is suitable and what it will involve.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.